- Arvato Systems provides serialization for pharmaceutical company Ursapharm’s production sites around the world
- Ursapharm will implement Arvato Systems proven serialization solution
The international importance of the issue of drug security has increased from both an industry and a political point of view. EU delegated regulations stipulate that from Feb 9, 2019 all prescribed medicines may only be sold when packaging has unique serial number. Other countries, such as the USA, already have similar legislation in place, while important markets such as China and Turkey are in the process of implementing directives in this area. The common goal is to prevent counterfeit drugs from entering the legal supply chain.
Ursapharm has decided to respond to the upcoming challenges by implementing Arvato Systems’ complete IT solution. The Arvato Corporate Serialization Database, Arvato CSDB encompasses the complete pharmaceutical manufacturing process: generating and managing serial numbers, communicating with the production lines and registering numbers into the national verification system.
“With sales offices in more than 60 countries, including Russia, France, the Netherlands and India, and as a contractor with partners around the world, we were in the market for a proven IT solution to meet the requirements of national and international directives,” comments Ivica Saric, Head of IT and Validation coordinator for Ursapharm.“ In Arvato Systems we have a partner at our side who, in Arvato CSDB, can offer us a reliable and proven IT solution”.
Ursapharm is a medium sized company, active in many areas around the world. With a broad range of ophthalmic products, it is a leader in the German market. The portfolio is rounded out with a range of general medical products. In addition, as a highly productive contract manufacturer, Ursapharm offers expertise in development, production, quality control and quality assurance to partners worldwide.